Literature DB >> 15688289

Lack of human herpesvirus 8 infection in lungs of Japanese patients with primary pulmonary hypertension.

Harutaka Katano1, Kinji Ito, Kazutoshi Shibuya, Tsutomu Saji, Yuko Sato, Tetsutaro Sata.   

Abstract

Samples of lung tissue, taken at autopsy, from 10 Japanese patients with primary pulmonary hypertension (PPH) and samples of lung tissue from 12 Japanese patients with secondary pulmonary hypertension were tested for the presence of human herpesvirus 8 (HHV-8). All samples from patients with PPH contained plexiform lesions around pulmonary arterial vessels, but immunohistochemistry failed to detect the HHV-8-encoded latency-associated nuclear antigen. HHV-8 DNA could not be amplified by polymerase chain reaction for the HHV-8-encoded K1 and KS330(233) genes in any sample. These data suggest that HHV-8 infection is not associated with PPH in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688289     DOI: 10.1086/427824

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 2.  Linking KSHV to human cancer.

Authors:  Emily L Wong; Blossom Damania
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

Review 3.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

Review 4.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

5.  Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension.

Authors:  Priscilla Y Hsue; Steven G Deeks; Husam H Farah; Swapna Palav; Samira Y Ahmed; Amanda Schnell; Allison B Ellman; Laurence Huang; Sheila C Dollard; Jeffrey N Martin
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

6.  Human herpesvirus 8 and pulmonary hypertension.

Authors:  Emanuele Nicastri; Carmine Dario Vizza; Fabrizio Carletti; Stefania Cicalini; Roberto Badagliacca; Roberto Poscia; Giuseppe Ippolito; Francesco Fedele; Nicola Petrosillo
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

7.  Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review.

Authors:  Elham Atabati; Amir Dehghani-Samani; Sayyed Gholamreza Mortazavimoghaddam
Journal:  Can J Respir Ther       Date:  2020-11-26

Review 8.  Novel insights on the pulmonary vascular consequences of COVID-19.

Authors:  François Potus; Vicky Mai; Marius Lebret; Simon Malenfant; Emilie Breton-Gagnon; Annie C Lajoie; Olivier Boucherat; Sébastien Bonnet; Steeve Provencher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-17       Impact factor: 5.464

Review 9.  Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.

Authors:  Benjamin J Dunmore; Rowena J Jones; Mark R Toshner; Paul D Upton; Nicholas W Morrell
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

10.  Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.

Authors:  Hannah J Durrington; Paul D Upton; Simon Hoer; Jessica Boname; Benjamin J Dunmore; Jun Yang; Trina K Crilley; Lynn M Butler; David J Blackbourn; Gerard B Nash; Paul J Lehner; Nicholas W Morrell
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.